Evidence map›Paper›PMID 30813323›Full record

ReviewPharmaceutics2019

Marie Wahlgren, Magdalena Axenstrand, Åsa Håkansson, Ali Marefati, Betty Lomstein Pedersen

Open access · goldAbstract readReview
In one paragraph

Review in Pharmaceutics, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
5.4field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 60 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Review
  15. Powering Implantable and Ingestible Electronics.Advanced functional materials · 2021
    Article
  16. Review
  17. Review
  18. Article
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 2 countries.

Marie WahlgrenDepartment of Food technology engineering and nutrition, Lund University, P.O. Box 124, 221 00 Lund, Sweden. marie.wahlgren@food.lth.se.ORCID 0000-0002-1705-3964
Magdalena AxenstrandDepartment of Food technology engineering and nutrition, Lund University, P.O. Box 124, 221 00 Lund, Sweden. magdalenaaxenstrand@gmail.com.
Åsa HåkanssonDepartment of Food technology engineering and nutrition, Lund University, P.O. Box 124, 221 00 Lund, Sweden. asa.hakansson@food.lth.se.
Ali MarefatiDepartment of Food technology engineering and nutrition, Lund University, P.O. Box 124, 221 00 Lund, Sweden. ali.marefati@food.lth.se.
Betty Lomstein PedersenFerring International PharmaScience Center (IPC), Kay Fiskers Plads 11, 2300 Copenhagen, Denmark. Betty.Pedersen@ferring.com.
Lund University · SEFerring Pharmaceuticals (Denmark) · DK

Funding

VINNOVA 11VINNOVA Nextbioform
6 · The paper itself

Abstract

The primary focus of this review is a discussion regarding in vitro media for colon release, but we also give a brief overview of colon delivery and the colon microbiota as a baseline for this discussion. The large intestine is colonized by a vast number of bacteria, approximately 10

Indexed as

colon deliverycolon microbiotain vitro systems

Identifiers

PMID30813323
PMCPMC6410320
OpenAlexW2915532549

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.